In conclusion, BCL2 expression evaluated by AQUA scoring system incorporating both intensity and proportion of BCL2 was an independent prognostic factor in patients with DLBCL treated with R-CHOP. Here, BCL2 is linked to diffuse large B-cell lymphoma.